Stock report · Delisted · NYSE American
NovaBay Pharmaceuticals Inc (NBY)
1.21USD Delisted Final close · Jun 4, 2026
NBY no longer trades. NovaBay Pharmaceuticals was delisted from the NYSE American in June 2026.
All prices on this page are historical. The last trade was on June 4, 2026, at $1.21.
NBY stock price history
Final trading statistics
- Final close
- $1.21
- Final trading day
- Jun 4, 2026
- Market cap at delisting
- $32.22M
- Shares outstanding
- 26.63M
- Final 52-week range
- $0.43 – $19.95
- Avg. volume (final 3 mo.)
- 409,182
- All-time high
- $405885.06 · Nov 2007
- All-time low
- $1.15 · Jun 2026
- Return since IPO
- -80.1%
- Beta
- 0.16
- Book value / share
- −$0.92
- Price / book
- -1.32
About NovaBay Pharmaceuticals Inc
NovaBay Pharmaceuticals, Inc. built up and held digital assets in order to take part in blockchain networks. Its focus was SKY, the protocol token of the decentralized Sky Protocol, which it aimed to use for staking, governance, validation and similar protocol-level activities.
Incorporated in 2000 and based in Emeryville, California, the company was called NovaCal Pharmaceuticals, Inc. until February 2007. It was delisted from the NYSE American in June 2026, with a final trade on June 4, 2026 at $1.21.
- Exchange (former)
- NYSE American
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Emeryville, CA
- Employees
- 2
- IPO date
- October 26, 2007
- Delisted
- June 4, 2026
- SEC CIK
- 1389545
NovaBay Pharmaceuticals financials before the delisting
The last 5 fiscal years NovaBay Pharmaceuticals reported as a public company, fiscal year ending December.
NBY revenue and net income
NBY earnings per share
NBY annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | −$22.1M | — |
| FY2024 | $9.78M | −$7.2M | −$4.10 |
| FY2023 | $10.46M | −$9.6M | −$3.19 |
| FY2022 | $14.40M | −$10.6M | −$7.43 |
| FY2021 | $10.20M | −$5.8M | −$5.25 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
NovaBay Pharmaceuticals stock FAQ
What happened to NovaBay Pharmaceuticals stock?
NovaBay Pharmaceuticals was delisted from the NYSE American in June 2026. The final close was $1.21 on June 4, 2026.
Can I still buy NBY stock?
No. NBY is no longer listed on the NYSE American or any other U.S. exchange; it was removed on June 4, 2026.
What was the last price of NBY?
NBY last closed at $1.21 on June 4, 2026, which valued the company at about $32.22M.
How did NovaBay Pharmaceuticals do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, NovaBay Pharmaceuticals reported revenue of $0.00 and net income of −$22.1M.
When did NovaBay Pharmaceuticals go public?
NovaBay Pharmaceuticals shares started trading on October 26, 2007.
NBY no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.